Lexicon Pharmaceuticals, Inc.
USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENT

Last updated:

Abstract:

The invention relates to the use of sotagliflozin inpatients with type 2 diabetes mellitus and moderate renal impairment.

Status:
Application
Type:

Utility

Filling date:

24 Jul 2020

Issue date:

25 Aug 2022